The FDA realizes that it ain’t perfect

Many people, including myself, have questioned the benefit of the Food and Drug Administration. I was delighted to read this article.

Commercialized therapies weren't helping the Florida infant, and his doctors at Holtz Children's Hospital in Miami were desperate. So they called Baltimore's Osiris Therapeutics and asked a costly favor: They wanted free access to one of the company's experimental, unapproved and expensive stem cell treatments, allowable under a provision within federal regulations. Osiris said OK.

"After he was given the drug, he improved 100 percent," the boy's father, Hilario Rojo, said last week through a Spanish-speaking interpreter. Today, the toddler is 28 months old and faring well.

There is hope for us yet!